Avantor, Inc. (NYSE:AVTR) CAO Sells $86,019.71 in Stock

Avantor, Inc. (NYSE:AVTR - Get Free Report) CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares of the company's stock, valued at $711,788.12. This represents a 10.78 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Avantor Stock Down 2.1 %

Shares of NYSE AVTR traded down $0.34 during midday trading on Tuesday, hitting $15.54. 5,270,823 shares of the company's stock were exchanged, compared to its average volume of 5,791,369. The firm's fifty day simple moving average is $20.41 and its 200-day simple moving average is $22.58. The company has a market cap of $10.58 billion, a PE ratio of 14.96, a P/E/G ratio of 1.55 and a beta of 1.28. Avantor, Inc. has a twelve month low of $15.37 and a twelve month high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the previous year, the company earned $0.22 EPS. Research analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Remove Ads

Analyst Ratings Changes

A number of brokerages have weighed in on AVTR. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Raymond James restated an "outperform" rating and issued a $24.00 price objective (down from $26.00) on shares of Avantor in a report on Monday, February 10th. Royal Bank of Canada dropped their target price on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a report on Monday, February 10th. Wells Fargo & Company reduced their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Finally, Barclays dropped their price objective on shares of Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $25.50.

Hedge Funds Weigh In On Avantor

Hedge funds have recently made changes to their positions in the company. Creative Planning grew its stake in Avantor by 54.0% during the 3rd quarter. Creative Planning now owns 28,136 shares of the company's stock worth $728,000 after buying an additional 9,866 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Avantor by 4.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 28,012 shares of the company's stock valued at $725,000 after acquiring an additional 1,091 shares during the period. State of Alaska Department of Revenue purchased a new position in shares of Avantor during the third quarter worth approximately $2,043,000. Nisa Investment Advisors LLC increased its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after acquiring an additional 835 shares during the period. Finally, New York State Teachers Retirement System purchased a new stake in Avantor in the 3rd quarter valued at $8,473,000. Hedge funds and other institutional investors own 95.08% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.